Severity of Bronchopulmonary Dysplasia in Infants Born Extremely Preterm and Randomized to Early Human Milk Fortification with a Donor Milk-Derived Fortifier for 2 Weeks.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 40714049.
- Also identified by DOI 10.1016/j.jpeds.2025.114750 and PMC identifier 12382184.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this secondary analysis of a masked clinical trial involving 150 infants born extremely preterm randomized to receive fortified milk starting on either postnatal day 3 (early group) or day 14 (delayed group), we found a significant difference in the distribution of bronchopulmonary dysplasia severity between the 2 groups (P = .039) with milder forms of bronchopulmonary dysplasia in the early group.
Medical subject headings
- Bronchopulmonary Dysplasia
- Food, Fortified
- Infant, Extremely Premature
- Milk, Human